Skip to main content
. 2016 Sep;11(9):1511–1521. doi: 10.1016/j.jtho.2016.05.028

Figure 2.

Figure 2

Kaplan-Meier plots for progression-free survival (PFS) according to the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.0, (A) and immune-related response criteria (B) and according to autoantibody status at baseline (C). CI, confidence interval; irRC, immune-related response criteria; NR, not reached.